期刊文献+

口服左氧氟沙星治疗化脓性扁桃体炎疗效分析 被引量:11

Efficacy of Orally Administered Levofloxacin in Treatment of Acute Suppurative Tonsillitis
下载PDF
导出
摘要 目的 评价左氧氟沙星治疗急性化脓性扁桃体炎的有效性。方法 120例急性化脓性扁桃体炎的患者随机分成两组,试验组给予口服左氧氟沙星片剂500mg,1次/d;对照组静脉滴注青霉素钠,480万单位/次,2次/d,疗程7~14d。结果 共109例完成试验,试验组57例,临床有效率为92.98%,细菌清除率为87.81%;对照组52例,临床有效率为90.38%,细菌清除率为82.86%,试验组与对照组临床有效率及细菌清除率相比较差异均无统计学意义(P〉0.05)。结论 口服左氧氟沙星500mg能有效地治疗急性化脓性扁桃体炎。 OBJECTIVE To evaluate the efficacy of orally administered levofloxacin 500mg for the treatment of acute suppurative tonsillitis, METHOD6 Totally 120 proper patients were randomized into 2 groups and either group was in 1 : 1 ratio. Patients in trial group received levofloxacin 500mg qd po. Patients in control group received benzylpenicillin sodium Ⅳ (4.8 million unit bid). The course of treatment was 7 - 14 days. RESULTS From them 109 patients completed the study, 57 in trial group and 52 in control group. The results showed that in trial group levofloxacin could reach the total clinical efficacy of 92. 98% and the bacterium eradication rate of 87. 81% while in cotrol group it was 90. 38% and 82.86%. There was no statistic significant difference between the two groups in total clinical efficacy and bacterium eradication rate (P〉0. 05). CONCLUSIONS Levofloxacin 500mg orally administered is effective in the treatment of acute suppurative tonsillitis,
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2007年第10期1268-1270,共3页 Chinese Journal of Nosocomiology
关键词 急性化脓性扁桃体炎 左氧氟沙星 疗效 Acute suppurative tonsillitis Levofloxacim Efficacy
  • 相关文献

参考文献10

二级参考文献28

  • 1Weiss LR. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis[J]. Clin Ther, 2002, 24(9): 1414-1425.
  • 2Shah PM, Maesen FP, Dolmann A, et al. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis : results of a randomized, double-blind study[J]. J Antimicrob Chemother, 1999, 43(4): 529-539.
  • 3Norrby SR, Petermann W, Willcox PA, et al. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia[J]. Scand J Infect Dis, 1998,30(4) : 397-404.
  • 4Decousser JW, Allouch PY, Courvalin P, et al. In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France : a national survey[J]. Int J Antimicrob Agents, 2002, 20(3): 186-195.
  • 5Hurst M, Lamb HM, Scott LJ, et al. Levofloxacin: an updated review of its use in the treatment of bacterial infections[J].Drugs 2002, 62(14): 2127-2167.
  • 6中华人民共和国卫生部医政司.全国临床检验操作规程:第2版[M].东南大学出版社,1997.204.
  • 7American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia diagnosis, assessment of severity,antimicrobial therapy and prevention[J]. Am J Respir Crit Care Med,2001,163(4):1730-1754.
  • 8Bartlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults:guidelines for management. The Infectious Diseases Society of America[J]. Clin Infect Dis,2000,26(2):811-838.
  • 9Furst M, Lamb HM. Levofloxacin. An updated review of its use in the treatment of bacterial infection[J]. Drug, 2002,62(5):2127-2167.
  • 10Frank E, Liu J, Kinasewitz G, et al. A muticenter, open-labeled randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia[J]. Clin Ther, 2002, 24: 1292-1308.

共引文献62

同被引文献43

引证文献11

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部